RTW Biotech Opportunities (RTW) Competitors GBX 1.56 +0.01 (+0.65%) As of 12:28 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock RTW vs. DVNO, PMGR, TPVE, YOLO, FFWD, JTWO, TFG, VEN2, SVCT, and KZGShould you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include Develop North (DVNO), Premier Miton Glb Renewables Trust (PMGR), Triple Point Income VCT Plc E (TPVE), Yolo Leisure and Technology (YOLO), Fastforward Innovations (FFWD), J2 Acquisition (JTWO), Tetragon Financial (TFG), Ventus 2 VCT (VEN2), Seneca Growth Capital VCT (SVCT), and Kazera Global (KZG). These companies are all part of the "asset management" industry. RTW Biotech Opportunities vs. Its Competitors Develop North Premier Miton Glb Renewables Trust Triple Point Income VCT Plc E Yolo Leisure and Technology Fastforward Innovations J2 Acquisition Tetragon Financial Ventus 2 VCT Seneca Growth Capital VCT Kazera Global Develop North (LON:DVNO) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership. Is DVNO or RTW more profitable? RTW Biotech Opportunities has a net margin of 664.38% compared to Develop North's net margin of 59.58%. RTW Biotech Opportunities' return on equity of 25.18% beat Develop North's return on equity.Company Net Margins Return on Equity Return on Assets Develop North59.58% 4.24% 1.11% RTW Biotech Opportunities 664.38%25.18%-0.47% Which has higher earnings & valuation, DVNO or RTW? RTW Biotech Opportunities has lower revenue, but higher earnings than Develop North. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than Develop North, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDevelop North£1.57M11.16£846.72K£0.041,650.94RTW Biotech Opportunities-£86.75M-0.06£14.09B-£0.26-6.00 Which has more volatility & risk, DVNO or RTW? Develop North has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. Comparatively, RTW Biotech Opportunities has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Do insiders and institutionals believe in DVNO or RTW? 3.4% of RTW Biotech Opportunities shares are held by institutional investors. 0.8% of Develop North shares are held by insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media prefer DVNO or RTW? In the previous week, RTW Biotech Opportunities had 1 more articles in the media than Develop North. MarketBeat recorded 1 mentions for RTW Biotech Opportunities and 0 mentions for Develop North. RTW Biotech Opportunities' average media sentiment score of 0.84 beat Develop North's score of 0.00 indicating that RTW Biotech Opportunities is being referred to more favorably in the news media. Company Overall Sentiment Develop North Neutral RTW Biotech Opportunities Positive SummaryRTW Biotech Opportunities beats Develop North on 7 of the 13 factors compared between the two stocks. Get RTW Biotech Opportunities News Delivered to You Automatically Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RTW vs. The Competition Export to ExcelMetricRTW Biotech OpportunitiesAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£5.11M£1.48B£6.46B£2.61BDividend YieldN/A4.59%4.31%5.28%P/E Ratio-6.003,116.271,345.554,442.02Price / Sales-0.061,964.351,359.91100,236.46Price / Cash0.3260.47127.6527.90Price / Book0.011.373.539.02Net Income£14.09B£264.59M£1.22B£5.89B7 Day Performance0.97%0.42%1.14%0.49%1 Month Performance4.00%1.44%7.09%5.62%1 Year Performance0.65%9.30%39.97%164.56% RTW Biotech Opportunities Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RTWRTW Biotech OpportunitiesN/AGBX 1.56+0.6%N/A+2.1%£5.11M-£86.75M-6.004,971News CoverageHigh Trading VolumeDVNODevelop NorthN/AGBX 77flatN/A+0.0%£19.23M£1.57M1,816.04N/AGap DownPMGRPremier Miton Glb Renewables TrustN/AGBX 103.30-0.7%N/A-3.0%£18.84M-£5.42M-276.20N/AHigh Trading VolumeTPVETriple Point Income VCT Plc EN/AN/AN/AN/A£18.09M£4.35M781.25N/AYOLOYolo Leisure and TechnologyN/AN/AN/AN/A£17.57M£14K-12.502News CoverageFFWDFastforward InnovationsN/AN/AN/AN/A£17.55M-£4.19M-2.50N/AJTWOJ2 AcquisitionN/AN/AN/AN/A£15.97M£3.88B-1.97N/ATFGTetragon FinancialN/AGBX 19.13-0.4%N/AN/A£15.93M£724.60M2.41N/AVEN2Ventus 2 VCTN/AN/AN/AN/A£15.82M£9.47M1.98N/AGap DownSVCTSeneca Growth Capital VCTN/AGBX 46flatN/AN/A£15.32M-£3.51M-2,705.88N/AKZGKazera GlobalN/AGBX 1.55-0.1%N/A+19.5%£15.23MN/A-703.6429Gap Down Related Companies and Tools Related Companies DVNO Alternatives PMGR Alternatives TPVE Alternatives YOLO Alternatives FFWD Alternatives JTWO Alternatives TFG Alternatives VEN2 Alternatives SVCT Alternatives KZG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:RTW) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersTesla’s $30 trillion pivotCircle Nov 6 – huge Tesla news? Tesla could be about to change forever. On November 6, insiders are warning...Altimetry | SponsoredBitcoin at $125,000 is fantastic news… for this coinAs Bitcoin surges past $125,000, one under-the-radar altcoin — faster, cheaper, and already backed by major in...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredAn Early Move On The Next Shift In CoinLitecoin is already processing 500,000+ daily transactions, integrated with PayPal and Revolut, and now one fi...Market Tactic | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
